Missing Quorum, Nanogen and Epoch Postpone Merger Vote | GenomeWeb

NEW YORK, Dec. 8 (GenomeWeb News) - Nanogen and Epoch Biosciences adjourned their special shareholder meetings today and postponed until Dec. 15 a vote on their merger after an insufficient number of stockholders were present or represented by proxy at the Nanogen meeting.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.